论文部分内容阅读
目的:探讨采用阿莫西林、碳酸铝镁片、兰索拉唑三联疗法治疗消化性溃疡的临床疗效。方法:选取2015.6~2016.12该院160例消化性溃疡患者,按治疗方案的不同将其平分为常规、研究组,每组患者80例。对常规组单纯给予兰索拉唑,对研究组采用阿莫西林、碳酸铝镁片、兰索拉唑三联疗法,并分析对比两组临床疗效。结果:研究组及常规组临床总有效率分别为97.50%、83.75%,研究组有效率高于常规组,P<0.05。结论:相较于单一用药,采用阿莫西林、碳酸铝镁片、兰索拉唑三联疗法,可对促进溃疡愈合、缓解临床症状、提升临床疗效,具备临床实际使用意义与价值。
Objective: To investigate the clinical efficacy of amoxicillin, magnesium carbonate tablets and lansoprazole triple therapy in the treatment of peptic ulcer. METHODS: A total of 160 patients with peptic ulcer in our hospital from 2015.6 to 2016.12 were divided equally into two groups according to different treatment regimens: study group and study group, 80 cases in each group. Lansoprazole was given to the conventional group and the study group was treated with amoxicillin, magnesium aluminum carbonate and lansoprazole triple therapy, and the clinical efficacy was compared between the two groups. Results: The total clinical effective rates of the study group and the routine group were 97.50% and 83.75%, respectively. The effective rate of the study group was higher than that of the conventional group (P <0.05). Conclusion: Compared with a single drug, the use of amoxicillin, magnesium aluminum carbonate, Lansoprazole triple therapy can promote ulcer healing, relieve clinical symptoms and improve clinical efficacy, with clinical significance and value.